Vibrio cholerae O139 Bengal has recently been identified as a cause of epidemic cholera in Asia. In contrast to V. cholerae O1, V. cholerae O139 Bengal has a polysaccharide capsule. As determined by high-performance anion-exchange chromatography and 1 H nuclear magnetic resonance analysis, the capsular polysaccharide of V. cholerae O139 Bengal strain Al1837 has six residues in the repeating subunit; this includes one residue each of N-acetylglucosamine, N-acetylquinovosamine (QuiNAc), galacturonic acid (GalA), and galactose and two residues of 3,6-dideoxyxylohexose (Xylhex). The proposed structure is
The disease cholera has traditionally been attributed to cholera toxin-producing strains of Vibrio cholerae within O group 1 (V. cholerae O1) (14) . In October 1992, cases of cholera associated with a V. cholerae strain which did not agglutinate with O1 antisera were first noted in Madras, India (22) . During the next several months, this strain (designated V. cholerae O group 139, synonym Bengal) spread in epidemic form across India and Bangladesh and has now been introduced into much of the rest of Asia (5, 8, 11, 18, 20) . Molecular epidemiologic studies have demonstrated that V. cholerae O139 Bengal strains are virtually identical to V. cholerae O1 El Tor, the bioserogroup responsible for the seventh cholera pandemic, ongoing since 1961 (7, 18, 21) . However, in contrast to V. cholerae O1 (but in common with other non-O1 V. cholerae strains [12] ), V. cholerae O139 Bengal is encapsulated (13) . We report here our preliminary determination of the structure of the V. cholerae O139 Bengal capsular polysaccharide.
These studies utilized V. cholerae O139 Bengal strain Al1837; this strain was isolated from a cholera patient in Bangladesh and has been shown to cause cholera in healthy North American volunteers (19) . Methods for extraction of the capsular polysaccharide follow those previously described for non-O1 V. cholerae and other Vibrio species (12, 23) . The final preparation had Ͻ0.01% lipopolysaccharide (LPS), as determined by a standard Limulus amoebocyte lysate assay (Sigma).
Approximately 200 g of V. cholerae O139 polysaccharide was taken in a screw-cap Teflon tube (13 by 100 mm), and 200 l of aqueous trifluoroacetic acid was added. After hydrolysis in a heating block, the tube was cooled and the acid was removed by evaporation with nitrogen gas. The residue was dissolved in 200 l of water, and 10 l was used for each high-performance liquid chromatography (HPLC) injection. The system used for high-performance anion-exchange chromatography consisted of a BioLC gradient pump (Dionex Corp., Sunnyvale, Calif.) with a pulsed amperometric detector. A Carbopac PA1 pellicular anion-exchange column (4 by 250 mm; Dionex Corp.) equipped with Carbopac guard column was used with a flow rate of 1 ml/min at room temperature. In these experiments, eluant 1 was 16 mM NaOH (suitable for neutral and amino sugars) and eluant 2 was 100 mM NaOH plus 150 mM sodium acetate (suitable for acidic sugars). Detection was done with a pulsed amperometric detector, using a gold working electrode (9) .
Nuclear magnetic resonance (NMR) spectra were recorded at a 1 H frequency of 500 MHz on a General Electric GN500 spectrometer at 60ЊC with a reverse polarization transfer probe P spin echo experiments were done with delay periods ranging from 20 to 100 ms. All NMR data were processed on Silicon Graphics workstations running the FELIX program (Biosym Corp., San Diego, Calif.).
After acid hydrolysis with 0.05 M trifluoroacetic acid at 60ЊC for 3 h, carbohydrate analysis showed release of 3,6-dideoxyxylohexose which cochromatographed with an authentic sample of abequose in solvent 1. Hydrolysis for 10 h in 1 M trifluoroacetic acid at 100ЊC yielded peaks corresponding to quinovosamine, glucosamine, galactose, and a reduced amount of 3,6-dideoxyxylohexose, using elution conditions (solvent 1) which are suitable for neutral sugars (23) . Using HPLC conditions suitable for acidic sugars (solvent 2), a peak whose retention time corresponds to that of galacturonic acid (GalA) was detected, but the yield was less than stoichiometric apparently because of difficulty of cleaving the glycosidic linkages of uronic acids under conditions which do not degrade them.
The polysaccharide appears to be stable to degradation with a mild base. Treatment for 12 h with aqueous NH 4 OH (pH 11) at 4ЊC did not modify the NMR spectrum of the polysaccharide. 1 H NMR spectra of the polymer at room temperature show fairly broad lines with poor resolution, but at 60ЊC the spectra show reasonably narrow lines. The HMQC spectrum (Fig. 1) shows six resonances typical of anomeric C-H pairs between 98 and 103 ppm in the 13 C dimension and between 4.4 and 5.4 ppm in the 1 H dimension. The hypothesis that there are six residues in the repeating subunit was tested by tracing the connectivity of each pyranoside ring spin system from the anomeric 1 H signal, using established methods which allow identification of the sugar residue from coupling patterns (1) . A residue of ␤-N-acetylglucosamine (residue B) was identified by large coupling constants (7 to 11 Hz) for H1-H2, H2-H3, H3-H4, and H4-H5 along with a characteristic downfield chemical shift of the C2 resonance. (See Table 1 for resonance assignments.) A residue of ␤-N-acetylquinovosamine (␤-QuiNAc; residue A) was identified by large H-H coupling constants, a downfield shift for C2, and chemical shifts characteristic of a methyl group at C6. Two residues of ␣-3,6-dideoxyxylohexose (␣-3,6-dd-Xylhex; residues D and F) were similarly identified by homonuclear coupling constants, characteristic chemical shifts for the C3 and H3 methylene group and the C6 methyl group. A residue of ␤-galactose (␤-Gal; residue E) was identified by large coupling constants between H1-H2 and H2-H3 with small (1-to 3-Hz) couplings between H3-H4 and H4-H5. Large nuclear Overhauser effect cross-peaks were observed between H4 and H3 and H5 as well as between H1 and H3 and H5. The residue of ␣-galacturonic acid (residue C) was identified by a large coupling between H2-H3 and a small coupling between H1-H2 and between H3-H4 and H4-H5. Large nuclear Overhauser effect cross-peaks were observed between H1-H2 and between H4-H3 and H4-H5. A large HMBC crosspeak was observed between H1 and C3 and C5, as is characteristic of residues with the ␣-configuration (1, 17) . The anomeric configurations of all the residues were confirmed by values of 1 J C-H as measured by coupled HMQC spectra (Table  1 ).
An HMBC experiment with 13 C long low-power pulses selective for carbonyl carbon resonances was used to assign the three carbonyl carbon resonances observed in the direct 13 C spectrum. The data (not shown) indicate that two of the carbonyl carbon resonances are coupled to methyl protons typical of N-acetyl groups, showing that both amino sugars are N acetylated. The third carbonyl resonance is coupled to the narrow multiplet assigned to H5 of the ␣-GalA residue, confirming the identity of this residue.
Phosphate analysis showed 1 mol of phosphate per repeating unit which was not susceptible to digestion with alkaline phosphatase.
The 31 P NMR spectrum showed a single resonance at a chemical shift typical of phosphate. Table 1 . Long-range Cross-peaks between C1 and Hx were observed for the linkages between dideoxyxylohexose (residue D) and ␤-Gal, for dideoxyxylohexose (residue F) and GlcNAc (residue B), for GlcNAc and GalA, and for ␤-Gal and GlcNAc. Confirming evidence for the assignment of the linkage positions was observed in the NOESY spectrum, which showed cross-peaks between GalA H1 and QuiNAc H3, between dideoxyxylohexose (residue D) H1 and Gal H2, between dideoxyxylohexose (residue F) H1 and GlcNAc H4, and between Gal H1 and GlcNAc H3. The linkage between QuiNAc and GlcNAc was confirmed by the characteristic downfield chemical shift of GlcNAc C6. The chemical and NMR data indicate that the capsular polysaccharide of V. cholerae O139 has six pyranoside residues in the repeating subunit with the following linkage configuration:
At this point the absolute configurations of the monosaccharides have not been unambiguously determined. Therefore, the residues of 3,6-dideoxyxylohexose could be designated either as colitose (the L isomer) or as abequose (the D isomer).
V. cholerae O139 Bengal has a semirough LPS (10, 16). Comstock et al. and others (6, 25) have shown that a single transposon insertion can result in loss of both encapsulation and the ability to produce LPS beyond the core oligosaccharide, suggesting that the same genes are responsible for expression of the capsule and the addition of the short O antigen. Hisatsune and colleagues (10) have reported that the LPS (core and O antigen) of O139 Bengal strains contains colitose and fructose as terminal sugars, together with glucose, L-glycero-D-manno-heptose, glucosamine, and quinovosamine. Further studies will be necessary to fully elucidate the genetic and biochemical relationship between LPS and capsule in these strains.
To our knowledge, this is the first V. cholerae strain for which the structure of the capsular polysaccharide has been determined. In prior work, we have found that quinovosamine, glucosamine, and galactose are not uncommon constituents of capsular polysaccharides among strains of Vibrio vulnificus (9, 23, 24) . The 3,6-dideoxyxylohexose, in contrast, appears to be unusual among the members of the family Vibrionaceae, although abequose (and, to a lesser extent, colitose) is a recognized constituent of LPS O antigen side chains among Salmonella and Yersinia species (2, 4, 15) . Genes associated with capsule expression have now been cloned from V. cholerae O139 Bengal, including one 11-kb region which is not present in V. cholerae O1 (6). Portions of this region hybridize with other encapsulated strains of non-O1 V. cholerae and V. vulnificus, as well as strains in other Vibrio species. By knowing the structure of the O139 Bengal capsule (and with our growing knowledge of other Vibrio capsular polysaccharides and the genetic elements which control their expression), we can begin to define the genetic elements required for O139 Bengal capsule biosynthesis. 
